RDC 751/2022 comes into force tomorrow, March 1, 2023 RDC 751/2022, which provides for risk classification, notification and registration regimes, and labeling requirements and instructions for use of medical devices, enters into force tomorrow, March 1, 2023. With the publication of RDC 751/2022, several changes were made to the regulation [...]
UDI Implementation Deadline for Class I Devices - FDA 510(k) Exempt! We finally reach the UDI (Unique Device Identification) implementation deadline at the Food and Drug Administration (FDA) for class I devices – 510(k) exempt. After the extension given by the FDA in July of this year, moving the deadline [...]
RDC 751/2022: Risk classification, the notification and registration regimes, and the requirements for labeling and instructions for use for medical devices. Resolution - RDC no. 751, of september 15, 2022 was published yesterday (21/09) in the official Gazette of the Union, which provides for risk classification, notification and registration regimes, [...]
Anvisa updates rules for RDC nº 185/2001 - regulation of medical devices in Brazil Anvisa released on its website on Wednesday (14/09) a news informing about the update of the rules for regularization of medical devices in Brazil. According to Anvisa, the Collegiate Board approved the proposal that revises RDC 185/2001, [...]
Anvisa now requires digital signatures in medical device processes and petitions The National Health Surveillance Agency – ANVISA circulated this week through Solicita System the Circular Letter No. 1/2022/SEI/GGTPS/DIRE3/ANVISA, which mainly provides with guidelines for signatures in process and petition documents for medical devices. In this letter, Anvisa informs that [...]
PASSARINI GROUP is pleased to inform that PASSROD, one of the group's companies, has joined ABIMED Associação Brasileira da Indústria de Tecnologia para Saúde, entidade que aproxima indústria e governo, colaborando com a construção de políticas públicas voltadas ao setor, sendo também protagonista na criação de um ambiente favorável à [...]
